WOOJUNG BIO, Inc. (KOSDAQ:215380)
1,666.00
-10.00 (-0.60%)
Feb 19, 2025, 9:00 AM KST
WOOJUNG BIO Revenue
WOOJUNG BIO had revenue of 9.23B KRW in the quarter ending September 30, 2024, with 90.47% growth. This brings the company's revenue in the last twelve months to 49.14B, up 56.65% year-over-year. In the year 2023, WOOJUNG BIO had annual revenue of 38.62B, down -17.70%.
Revenue (ttm)
49.14B
Revenue Growth
+56.65%
P/S Ratio
0.47
Revenue / Employee
n/a
Employees
n/a
Market Cap
27.95B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 38.62B | -8.30B | -17.70% |
Dec 31, 2022 | 46.92B | 15.68B | 50.20% |
Dec 31, 2021 | 31.24B | -6.11B | -16.35% |
Dec 31, 2020 | 37.34B | 5.05B | 15.65% |
Dec 31, 2019 | 32.29B | 8.53B | 35.91% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 300.87T |
SK hynix | 57.73T |
LG Energy Solution | 25.62T |
Samsung Biologics | 4,364.39B |
Hyundai Motor Company | 170.28T |
Celltrion | 2,876.25B |
Kia Corporation | 104.63T |
NAVER | 10.39T |